Atrial Fibrillation, Atrial Tachycardia, Ventricular Tachycardia, Wpw
Conditions
Keywords
catheter ablation techniques
Brief summary
A program of research has been set up at St. George's Hospital, London studyng the practicalities of catheter ablation. The current practice of catheter ablation is being studied for a range of arrhythmias including PAF, persistent AF, advanced persistent AF and resistant WPW.
Detailed description
The study design will be a separate randomised clinical trial for each of the arrhythmias studied. There will be 1:1 randomisation to either the cryotherapy protocol or RF protocol. Arrhythmia patients already under the care of this cardiac centre, who have already opted for catheter ablation treatment will be approached to ask if they will also be willing to participate in this longterm research program. The protocols for each different arrhythmia are in line with current practice and knowledge and utilising current technology. In the program, the investigators have 1 or 2 protocols that mildly differ from conventional use but have already passed through initial experience with publication on this- this is the multi-catheter cryocatheter approach. Acute procedural outcomes, short, medium and longterm success will be recorded for each patient, in addition to patient or participant experience and quality of life outcomes. The catheter ablation research program has passed through ethical panel review in London and has the potential to become a multi-centre study.
Interventions
PROCEDURECryotherapy
Catheter ablation treatment for the treatment of the studied arrhythmias
PROCEDUREradiofrequency catheter ablation
Catheter ablation treatment for the treatment of the studied arrhythmias
Sponsors
St. George's Hospital, London
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
The physiologist analysing the Holter results and/or loop recorders for recurrence of arrhythmia will not know the randomised treatment for the study participant.
Intervention model description
This is a 1:1 randomised clinical controlled trial or a set of them, in our extensive program of research.
Eligibility
Sex/Gender
ALL
Age
18 Years to 88 Years
Healthy volunteers
No
Inclusion criteria
* Adult patients under the care of the Arrhythmia Service at St. George's Hospital with one of the studied arrhythmia (PAF, persistent AF etc), awaiting catheter ablation treatment will be eligible for inclusion to the program of research
Exclusion criteria
* Vulnerable patients will be excluded- e.g. active cancer, inability to consent * Paediatric patients will not be studied * Patients awaiting standard SVT catheter ablation treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recurrence of the treated arrhythmia at 6 months | 6 months | Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 6 months. The method for recording recurrence will be from Holter or via loop recorder download. |
| Recurrence of the treated arrhythmia at 12 months | 12 months | Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 12 months. The method for recording recurrence will be from Holter or via loop recorder download. |
| Recurrence of the treated arrhythmia at 24 months | 24 months | Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 24 months. The method for recording recurrence will be from Holter or via loop recorder download. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The rate of major adverse cerebrovascular and/or cardiovascular complications (defined as MI, CVA, vascular, oesophageal trauma, phrenic nerve injury) will be recorded | 24 months | A record of MACCE (MI, CVA, vascular, oesophageal trauma, phrenic nerve injury) will be recorded for all participants for 24 months |
| To record the patient quality of life improvement by filling in a Short Form-36 questionnaire | 24 months | The validated questionnaire is called the General Health Short Form-36 questionnaire. It is a general health questionnaire with 36 questions. The scoring system works from 0-100. The higher the score, the more favourable the general well-being of the patient or participant. |
Countries
United Kingdom
Contacts
Primary ContactAnu Taiwo, Bsc
Backup ContactLisa Leung, MBChB (Hons), MRCP (UK)
Outcome results
None listed